Mark Atkins
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 24
- Hepatitis B Virus Studies 19
- Liver Disease Diagnosis and Treatment 3
- Hepatology 17
- Hepatitis C virus research 16
- Hepatitis Viruses Studies and Epidemiology 4
- Co-authors
- Yun‐Fan Liaw (1 shared paper)Rong‐Nan Chien (1 shared paper)Ching‐Lung Lai (3 shared papers)Nathaniel Brown (3 shared papers)Jules L. Dienstag (3 shared papers)Mary Woessner (3 shared papers)Eugene R. Schiff (2 shared papers)Mark Nelson (9 shared papers)
- Journals
- Journal of Viral Hepatitis (3 papers)HIV Medicine (3 papers)AIDS (3 papers)PLoS ONE (3 papers)CHEST Journal (2 papers)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Mark Atkins
52 papers receiving 2.7k citations
Mark Atkins's Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 1.4k
- Epidemiology 2.1k
- Infectious Diseases 579
- Virology 110
- Critical Care and Intensive Care Medicine 55
Countries citing papers authored by Mark Atkins
This map shows the geographic impact of Mark Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Atkins more than expected).
Fields of papers citing papers by Mark Atkins
This network shows the impact of papers produced by Mark Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Atkins. The network helps show where Mark Atkins may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Atkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B Hit paper breakdown → | 2003 | 518 |
| 2 | 2008 | 298 | |
| 3 | 1999 | 248 | |
| 4 | 2002 | 248 | |
| 5 | 2007 | 143 | |
| 6 | 2003 | 128 | |
| 7 | 1999 | 125 | |
| 8 | 2001 | 107 | |
| 9 | 2005 | 100 | |
| 10 | 2006 | 85 | |
| 11 | 2012 | 77 | |
| 12 | 2011 | 73 | |
| 13 | 1991 | 66 | |
| 14 | 1996 | 63 | |
| 15 | 1994 | 63 | |
| 16 | 2000 | 38 | |
| 17 | 1994 | 38 | |
| 18 | 1999 | 38 | |
| 19 | 1995 | 38 | |
| 20 | 2012 | 34 |
About Mark Atkins
Mark Atkins is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Virology and Physiology, having authored 53 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (16 papers), HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (7 papers), Hepatitis Viruses Studies and Epidemiology (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Obstructive Sleep Apnea Research (2 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (2.1k citations), Infectious Diseases (579 citations), Virology (110 citations) and Critical Care and Intensive Care Medicine (55 citations). Mark Atkins has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Yun‐Fan Liaw, Rong‐Nan Chien, Ching‐Lung Lai, Nathaniel Brown, Jules L. Dienstag, Mary Woessner, Eugene R. Schiff, Mark Nelson, Lynn D. Condreay and Richard Boehme. Their work appears in journals such as Journal of Viral Hepatitis, HIV Medicine, AIDS, PLoS ONE and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.